A detailed history of Mercer Global Advisors Inc transactions in Organon & Co. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 31,086 shares of OGN stock, worth $663,996. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,086
Previous 30,540 1.79%
Holding current value
$663,996
Previous $575,000 11.83%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$17.45 - $21.96 $9,527 - $11,990
546 Added 1.79%
31,086 $643,000
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $54,058 - $73,752
3,923 Added 14.74%
30,540 $575,000
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $124,052 - $196,218
11,329 Added 74.1%
26,617 $384,000
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $37,095 - $53,149
2,236 Added 17.13%
15,288 $265,000
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $1,156 - $1,477
-60 Reduced 0.46%
13,052 $271,000
Q1 2023

May 15, 2023

BUY
$21.42 - $32.08 $23,412 - $35,063
1,093 Added 9.09%
13,112 $308,000
Q4 2022

Feb 08, 2023

BUY
$23.31 - $28.61 $38,321 - $47,034
1,644 Added 15.85%
12,019 $336,000
Q3 2022

Nov 15, 2022

BUY
$23.4 - $34.25 $53,047 - $77,644
2,267 Added 27.96%
10,375 $243,000
Q2 2022

Aug 10, 2022

SELL
$31.66 - $38.9 $28,209 - $34,659
-891 Reduced 9.9%
8,108 $273,000
Q1 2022

May 10, 2022

BUY
$30.45 - $39.36 $11,327 - $14,641
372 Added 4.31%
8,999 $314,000
Q4 2021

Feb 04, 2022

SELL
$28.67 - $37.13 $21,445 - $27,773
-748 Reduced 7.98%
8,627 $263,000
Q3 2021

Nov 10, 2021

BUY
$28.63 - $35.64 $40,396 - $50,288
1,411 Added 17.72%
9,375 $307,000
Q2 2021

Aug 10, 2021

BUY
$28.45 - $38.0 $226,575 - $302,632
7,964 New
7,964 $241,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.43B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.